An amino-acid sequence does not always define the complete molecule. N-terminal acetylation, C-terminal amidation, disulfides, cyclization, labels, linkers and non-standard residues must be stated explicitly.
What procurement and laboratory teams should review
Write the sequence in a defined N-to-C orientation
State terminal groups and every site-specific modification
Define disulfide connectivity or cyclization chemistry
Include stereochemistry and non-standard residue details
Define the molecular form before comparing offers
Sequence alone may not fully define a peptide material. Termini, modifications, disulfide pattern, counterion, hydration state and presentation can affect molecular-weight calculations, analytical reporting, solubility and handling.
- Record sequence, termini and every modification explicitly.
- State the requested salt or counterion form.
- Treat solubility and stability as material- and condition-specific.
Questions to resolve before quotation or release
- Is the requested structure linear, cyclic or branched?
- Which terminal groups are free, capped or amidated?
- Are labels, spacers or conjugation sites included in the mass calculation?
HK PEPTIDES custom RFQs should include a structure drawing or annotated sequence when the name alone cannot uniquely define the material.
Source material and further reading
This guide is informed by the following primary guidance and established technical resources. Always confirm the current version and its applicability to your material and jurisdiction.
HK PEPTIDES materials are supplied for laboratory research and documentation workflows only. They are not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.